We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Tiny Stent Leads to Half-Billion Dollar Offer from Alcon for Ivantis
Tiny Stent Leads to Half-Billion Dollar Offer from Alcon for Ivantis
Swiss company Alcon is paying $475 million to acquire device company Ivantis, developer of the Hydrus Microstent for surgical glaucoma, strengthening Alcon’s ophthalmology portfolio.